The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study. [electronic resource]
Producer: 20140211Description: 132-7 p. digitalISSN:- 1468-2060
- Adalimumab
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Arthritis, Psoriatic -- drug therapy
- Drug Therapy, Combination
- Etanercept
- Female
- Humans
- Immunoglobulin G -- administration & dosage
- Infliximab
- Longitudinal Studies
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.